Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00308776 · ClinicalTrials.gov registry record · NA
Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa
A NA study, sponsored by New York State Psychiatric Institute.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT00308776: Clinical Trial NA study, sponsored by New York State Psychiatric Institute.
NCT00308776 is a NA study that was terminated before completion, run by New York State Psychiatric Institute. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00308776, a NA study, was terminated before completion, sponsored by New York State Psychiatric Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study will determine the effectiveness of administrating a dose of cholecystokinin during a binge eating episode in reducing this eating behavior in people with bulimia nervosa.
Interventions
- PROCEDURE Cholecystokinin (CCK) infusion
- PROCEDURE Saline infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2003-10 |
| Est. Completion | 2008-10 |
| Phase | NA |
Why NCT00308776 stopped before completion
NCT00308776 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Cholecystokinin (CCK) infusion is the first listed.
NCT00308776 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00308776 about?
NCT00308776 is a clinical study titled "Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa". This study will determine the effectiveness of administrating a dose of cholecystokinin during a binge eating episode in reducing this eating behavior in people with bulimia nervosa.
What is the current status of trial NCT00308776?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2003-10. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00308776?
The interventions under investigation include: Cholecystokinin (CCK) infusion (PROCEDURE), Saline infusion (PROCEDURE).
Who is sponsoring clinical trial NCT00308776?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00308776's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia